http://www.denalitherapeutics.com
Denali Therapeutics Inc. Company Intro
Denali Therapeutics is dedicated to defeating neurodegenerative diseases through rigorous therapeutic discovery and development.
Industry
Healthcare
Denali Therapeutics Inc. Headquaters
161 Oyster Point Boulevard
South San Francisco,94080
United States
Denali Therapeutics Inc. Share price
22 Jan 2021 01:30 GMT
$77.65
0.14 (0.18 %)
Denali Therapeutics Inc. Market cap
$9.018 B
WMC RANKING
2021
Denali Therapeutics Inc. # 128
BiotechnologyLatest Denali Therapeutics Inc. News
22 Jan 2021
Mucopolysaccharidosis Market : Size & Trends Shows a ...
... Inc., Sangamo Therapeutics, Denali Theraputics, Bioasis Technologies Inc., and Paradigm Biopharmaceuticals Ltd. among other domestic and global players.
22 Jan 2021
Hunter Syndrome Treatment Market 2021 Overview, Trends ...
... are Takeda Pharmaceutical Company Limited., Green Cross Corporation., JCR Pharmaceuticals Co. Ltd., Regenxbio Inc., GC Pharma, Denali Therapeutics., ...
22 Jan 2021
Jan 22, 2021 - Windmill Hill Asset Management Ltd Buys SSGA SPDR S&P 500 Fossil Fuel Free ETF, iShares MSCI China ETF, VanEck Vectors Gold Miners ETF, Sells BTC iShares Core S&P 500 ETF, SSgA SPDR Gold Shares, BTC iShares Latin America 40 ETF
The impact to a portfolio due to this purchase was 1.45%. The holding were 65,010 shares as of 2020-12-31. New Purchase: Denali Therapeutics Inc (DNLI).
WMC Market Score
WMC Market to Revenue Score
Denali Therapeutics Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Denali Therapeutics Inc. | USD | $26,678 | $239,862 | $-197,614 | $90,180B | 128 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $571,390B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $345,270B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $620,550B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,640B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Denali Therapeutics Inc. Social Followers vs Top 4 Industry Competitors
Denali Therapeutics Inc. Post vs Top 4 Industry Competitors
Denali Therapeutics Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Denali Therapeutics Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Denali Therapeutics Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Denali Therapeutics Inc. | 0.29 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.33 | 29.44 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.28 | 100 | 60 | 0 | 0 | 90.10 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.77 | 86 | 0 | 0 | 99.40 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
